Avania Acquires Anagram

October 8, 2024

Avania, a global MedTech contract research organization (CRO), has acquired Anagram, a Barcelona-based MedTech CRO, to expand its CRO footprint into Spain and Southern Europe. The acquisition adds Anagram’s imaging core lab and therapeutic expertise in cardiology, neurology and oncology, strengthening Avania’s regional presence and clinical capabilities.

Buyers
Avania
Targets
Anagram
Location
Catalonia, Spain
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.